These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 1406889

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S, Korzets Z, Hershkovitz R, Bernheim J, Schneider M, Bernheim J.
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract] [Full Text] [Related]

  • 6. Thrombolytic therapy for myocardial infarction.
    Andreotti F.
    N Engl J Med; 1998 Feb 19; 338(8):546; author reply 547. PubMed ID: 9471558
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
    Kandzari DE, Granger CB, Simoons ML, White HD, Simes J, Mahaffey KW, Gore J, Weaver WD, Longstreth WT, Stebbins A, Lee KL, Califf RM, Topol EJ, Global Utilization of Streptokinase and tPA for Occluded Arteries-I Investigators.
    Am J Cardiol; 2004 Feb 15; 93(4):458-61. PubMed ID: 14969623
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage.
    Berridge DC, Makin GS, Hopkinson BR.
    Br J Surg; 1989 Dec 15; 76(12):1230-3. PubMed ID: 2514002
    [Abstract] [Full Text] [Related]

  • 10. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L, Lüderitz B.
    Dtsch Med Wochenschr; 1996 Mar 29; 121(13):424. PubMed ID: 8681737
    [No Abstract] [Full Text] [Related]

  • 11. Strokes and net clinical benefit.
    White H.
    Aust N Z J Med; 1993 Dec 29; 23(6):737-8. PubMed ID: 8141714
    [Abstract] [Full Text] [Related]

  • 12. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.
    Lessler DS, Avins AL.
    Arch Intern Med; 1992 Aug 29; 152(8):1665-72. PubMed ID: 1497400
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE, Colucci RD, Ujhelyi MR, Kluger J, Fieldman A, Chow MS.
    Pharmacotherapy; 1992 Aug 29; 12(6):440-4. PubMed ID: 1492007
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thrombolysis for stroke in the over 80s.
    Ford GA.
    Age Ageing; 2004 Mar 29; 33(2):95-7. PubMed ID: 14960420
    [No Abstract] [Full Text] [Related]

  • 19. Thrombolytic therapy for elderly patients.
    Topol EJ, Califf RM.
    N Engl J Med; 1992 Jul 02; 327(1):45-7. PubMed ID: 1598101
    [No Abstract] [Full Text] [Related]

  • 20. Thrombolytic therapy for coronary occlusion.
    Thompson PL.
    Med J Aust; 1992 Jul 20; 157(2):75-7. PubMed ID: 1630392
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.